261 related articles for article (PubMed ID: 6974629)
1. Manifestation and growth of a transplantable osteosarcoma in mice: the effects of thymectomy and thymosin treatment.
Carlsson SR; Stigbrand T; Boquist L; Lundgren E; Winblad B; Larsson SE
Clin Orthop Relat Res; 1981 Sep; (159):279-85. PubMed ID: 6974629
[TBL] [Abstract][Full Text] [Related]
2. In vitro induction of Lyt surface markers on precursor cells incubated with thymosin polypeptides.
Ahmed A; Smith AH; Wong DM; Thurman GB; Goldstein AL; Sell KW
Cancer Treat Rep; 1978 Nov; 62(11):1739-47. PubMed ID: 310340
[TBL] [Abstract][Full Text] [Related]
3. [Thymosin activation of T-killer precursors for hematopoietic stem cells].
Chermeneva LM; Arion VIa; Gladysheva TV; Petrov RV; Khaitov RM
Biull Eksp Biol Med; 1978 May; 85(5):602-5. PubMed ID: 306843
[TBL] [Abstract][Full Text] [Related]
4. In vivo generation of suppressor T cells by thymosin in congenitally athymic nude mice.
Marshall GD; Thurman GB; Rossio JL; Goldstein AL
J Immunol; 1981 Feb; 126(2):741-4. PubMed ID: 6161188
[TBL] [Abstract][Full Text] [Related]
5. Effect of thymosin treatment on antituberculous immunity in immunosuppressed mice.
Collins FM; Auclair LK
J Reticuloendothel Soc; 1979 Aug; 26(2):143-53. PubMed ID: 385871
[No Abstract] [Full Text] [Related]
6. Immunomodulation of murine B16 melanoma metastasis: thymosin, thymectomy and irradiation.
Naylor PH; Bhakoo HS; Paolini NS; Goldstein AL; Rosen F
Thymus; 1983 Sep; 5(5-6):355-61. PubMed ID: 6659023
[TBL] [Abstract][Full Text] [Related]
7. Production of substances with thymosin-like activity by B- and T-lymphocytes.
Nikolsky IS; Seleznyova TN; Zamotayeva GA; Martynenko SV; Grinevich YuA
J Hyg Epidemiol Microbiol Immunol; 1990; 34(3):309-14. PubMed ID: 2273248
[TBL] [Abstract][Full Text] [Related]
8. [Modulation of suppressor activity by thymosin].
Cupissol D; Thierry C; Serrou B
C R Seances Soc Biol Fil; 1981; 175(2):235-41. PubMed ID: 6454471
[TBL] [Abstract][Full Text] [Related]
9. [Factors controlling the recirculation of hematopoietic stem cells. IV. The effect of thymosin on the migration and differentiation of hematopoietic stem cells].
Khaitov RM; Chermeneva LM; Riabova LV
Tsitologiia; 1979 Sep; 21(9):1058-64. PubMed ID: 505578
[TBL] [Abstract][Full Text] [Related]
10. Decrease of tumor growth in mice after intravenous thymosin-treated bone marrow cell injection.
Cupissol D; Rey A; Goldstein AL; Serrou B
J Natl Cancer Inst; 1982 Jul; 69(1):27-31. PubMed ID: 7047833
[TBL] [Abstract][Full Text] [Related]
11. Experiences with thymosin in primary immunodeficiency disease.
Astaldi A; Astaldi GC; Wijermans P; Dagna-Bricarelli F; Kater L; Stoop JW; Vossen JM
Cancer Treat Rep; 1978 Nov; 62(11):1779-85. PubMed ID: 215306
[TBL] [Abstract][Full Text] [Related]
12. Resistance to L1210 mouse leukemia cells in moderately protein-malnourished BALB/c mice treated in vivo with thymosin fraction V.
Petro TM; Watson RR
Cancer Res; 1982 Jun; 42(6):2139-45. PubMed ID: 6804089
[TBL] [Abstract][Full Text] [Related]
13. T-cell levels and response to thymosin in vitro during intensive chemotherapy in cancer patients receiving thymosin.
Goldberg NH; Lipson SD; Kenady DE; Simon RM; Cohen MH; Chretien PB
Surg Forum; 1977; 28():151-2. PubMed ID: 214880
[No Abstract] [Full Text] [Related]
14. Therapeutic possibilities of thymopoietin fragments (TP3 and TP4) based on experimental animal models.
Dénes L; Szende B; Hajós G; Szporny L; Lapis K
Drugs Exp Clin Res; 1987; 13(5):279-87. PubMed ID: 3500029
[TBL] [Abstract][Full Text] [Related]
15. Thymosin in cancer patients: in vitro effects and correlations with clinical response to thymosin immunotherapy.
Chretien PB; Lipson SD; Makuch R; Kenady DE; Cohen MH; Minna JD
Cancer Treat Rep; 1978 Nov; 62(11):1787-90. PubMed ID: 215307
[TBL] [Abstract][Full Text] [Related]
16. [Effects of adult thymectomy on the growth of 203-glioma in mice--analysis of T cell subpopulation in tumor immunology].
Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
No To Shinkei; 1982 Nov; 34(11):1067-75. PubMed ID: 6984337
[TBL] [Abstract][Full Text] [Related]
17. Immunological reconstitution of T-cell-deprived mice. I. Inability of thymosin to restore spleen cell mitogen and tumor allograft response.
Primus FJ; De Martino L; MacDonald R; Hansen HJ
Cell Immunol; 1978 Jan; 35(1):25-33. PubMed ID: 145898
[No Abstract] [Full Text] [Related]
18. [Thymic polypeptide factor--thymalin in experiments and in clinical use].
Sofronov BN; Morozov VG; Khavinson VKh; Belokrylov GA
Fiziol Cheloveka; 1984; 10(2):229-33. PubMed ID: 6335878
[No Abstract] [Full Text] [Related]
19. [Effect of substances of a polypeptide nature isolated from the thymus, cerebral cortex and substantia alba on the cellular and humoral indices of immunity in thymectomized mice].
Belokrylov GA
Biull Eksp Biol Med; 1979 Jun; 87(6):572-4. PubMed ID: 313819
[TBL] [Abstract][Full Text] [Related]
20. [Effects of thymosin on human blood lymphocytes in vitro].
Kosmiadi GA; Grigor'eva MP; Korotaev GK; Il'intseva IE; Grigor'ev MIu
Vopr Onkol; 1979; 25(10):7-11. PubMed ID: 315663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
